Clinical Trial Update: Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating obeticholic acid in chronic hepatitis B patients with hepatic steatosis; trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Hepatitis B

Drugs mentioned

• Ocaliva (obeticholic acid)

Snippet

Sponsor: Assiut University | Conditions: Hepatitis B Virus, Steatosis | Phase 3 | Status: NOT_YET_RECRUITING